GlassScriptPhysician profile
Amy Mendus
NPI 1548668239
$1,466.31
in general payments reported to CMS, 2019-2025
17 companies · $282 in 2025
The $282 reported for 2025 was more than what 88% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $203 · 2023: $251 · 2024: $271 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.33 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.14 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $211.83 | 2023-2025 | Myfembree |
| Biogen, INC. | $191.53 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $189.64 | 2021-2025 | Wegovy |
| Agile Therapeutics, INC. | $93.63 | 2021-2024 | Twirla |
| Millicent US INC | $79.47 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Organon LLC | $72.38 | 2021-2024 | |
| Astellas Pharma US INC | $67.27 | 2023-2025 | Veozah |
| Medtronic, INC. | $51.83 | 2022-2023 | Truclear |
| Therapeuticsmd, INC. | $46.14 | 2021 | |
| Lilly USA, LLC | $39.11 | 2025 | Zepbound, Mounjaro |
| Exeltis, USA INC. | $34.20 | 2021-2022 | |
| Myovant Sciences INC. | $19.35 | 2021 | |
| Dexcom, INC. | $17.25 | 2024 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $17.01 | 2023 | Paragard T 380a |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.28 | 2023 | |
| Evofem Biosciences, INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mendus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.